Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing...
TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination...
TapImmune to Present at Two Upcoming Investor Conferences PR Newswire JACKSONVILLE, Fla., Sept. 25, 2018...
TapImmune To Present at 2018 Janney Healthcare Conference PR Newswire JACKSONVILLE, Fla., Sept. 12, 2018...
TapImmune to Participate at Two Upcoming Industry Conferences PR Newswire JACKSONVILLE, Fla., Aug. 29, 2018...
TapImmune Announces Pricing of $70 Million Private Placement Financing Led by New Enterprise Associates...
TapImmune to Present at the Jefferies 2018 Global Healthcare Conference PR Newswire JACKSONVILLE, Fla., May...
TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum PR...
TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics...
TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지